In a well-controlled inpatient study, 14 days of LC administration normalized the plasma glucose concentrations, decreased hemoglobin A1c (HbA1c), and improved insulin sensitivity by approximately 75% in the obese T2D patients [6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.